New predictive protocol for therapeutic treatment of renal and nonrenal anemias with recombinant human erythropoietin with a simple immunoenzymatic dosage of serum burst-promoting activity (IL-3, IL-4, GM-CSF)
Salvati
F
F
Strippoli
P
P
Scatizzi
A
A
Barchetti
M
M
Gaudio
R
R
Martella
A
A
Misserini
A
A
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D002985:Clinical Protocols; D004921:Erythropoietin / Q000008:administration & dosage*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000097:blood; D006801:Humans; D007377:Interleukin-3 / Q000097:blood; D015847:Interleukin-4 / Q000097:blood; D007676:Kidney Failure, Chronic / Q000150:complications
D007377:Interleukin-3; D004921:Erythropoietin; D015847:Interleukin-4; D016178:Granulocyte-Macrophage Colony-Stimulating Factor